1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA MMS22L CTRPv2 pan-cancer AAC 0.13 5e-05
mRNA EFCAB7 CTRPv2 pan-cancer AAC 0.13 5e-05
mRNA KIAA0408 CTRPv2 pan-cancer AAC 0.15 5e-05
mRNA HIST1H2BN CTRPv2 pan-cancer AAC -0.13 5e-05
mRNA ASCL5 CTRPv2 pan-cancer AAC 0.13 5e-05
mRNA ZNF473 CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA MYT1 CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA AGO4 CTRPv2 pan-cancer AAC 0.13 5e-05
mRNA GCH1 CTRPv2 pan-cancer AAC 0.13 5e-05
mRNA SDC4 CTRPv2 pan-cancer AAC -0.16 5e-05
Download CSV